Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Reiterates Outperform on Ameris, Raises Price Target to $71

Author: Benzinga Newsdesk | February 03, 2025 10:09am
Raymond James analyst David Feaster reiterates Ameris (NYSE:ABCB) with a Outperform and raises the price target from $67 to $71.

Posted In: ABCB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist